Invivyd Inc
Research Invivyd Inc (IVVD) on Bullrun: market cap USD 198.37M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIVVD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 198.37M
- Financial periodQ2 2026
- RevenueUSD 14.29M
- Net income-USD 44.39M
- Free cash flow-USD 43.52M
- Gross margin91.1%
Valuation Snapshot
latest market cap is USD 198.37M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 53.43M | -USD 52.49M | -USD 58.29M | 93.0% | -0.3 | USD 226.69M | USD 2.49M | USD 241.54M |
| FY2024 | USD 25.38M | -USD 169.93M | -USD 170.63M | 93.6% | -1.43 | USD 69.35M | USD 1.30M | USD 67.54M |
| FY2023 | USD 0 | -USD 198.64M | -USD 173.78M | n/a | -1.81 | USD 200.64M | USD 2.17M | USD 177.47M |
| FY2022 | USD 0 | -USD 241.32M | -USD 221.69M | n/a | -2.23 | USD 92.08M | USD 3.72M | USD 355.97M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 198.37M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 696.51M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 52.73M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 433.85M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 163.47M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 804.28M | n/a | n/a | n/a |
About Invivyd Inc
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Invivyd Inc's market cap?
Invivyd Inc's market capitalization is USD 198.37M.
What does Invivyd Inc do?
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand.